Article Information
History
- December 8, 2020.
Article Versions
- Version 1 (September 9, 2020 - 08:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kan Zhang1,2,3,*,
- Yuchen Feng1,2,*,
- Yuxia Liang1,2,
- Wenliang Wu1,2,
- Chenli Chang1,2,
- Dian Chen1,2,
- Shengchong Chen1,2,
- Jiali Gao1,2,
- Gongqi Chen1,2,
- Lingling Yi1,2,
- Dan Cheng4 and
- Guohua Zhen1,2,†
- 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Key Laboratory of Respiratory Diseases, National Health Commission of People’s Republic of China, and National Clinical Research Center for Respiratory Diseases, Wuhan, China
- 3Department of Respiratory and Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- 4Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China
- ↵†Correspondence to:
Guohua Zhen, Division of Respiratory and Critical Care Medicine, Tongji Hospital, Wuhan, China 430030; Email: ghzhen{at}tjh.tjmu.edu.cn
↵* KZ and YF contributed equally to this work.
Posted December 08, 2020.
An epithelial microRNA upregulates airway IL-25 and TSLP expression in type 2-high asthma via targeting CD39-extracellular ATP axis
